Search
01/06/2025
CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY
Azuaga, AB, Cuervo, A, Reina, D, Estrada, P, Soria, LM, Aparicio, M, Moreno, M, Arevalo, M, Laiz, A, Moya, P, Alascio, L, Riera, J, Scher, JU, Crespillo, JDDC, Ramirez, J. CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1990. PMID:. IF:20.600(Q1/1D).
01/06/2025
EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS
Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellví, I, Alvarez, ED. EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1643. PMID:. IF:20.600(Q1/1D).
01/06/2025
COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS
Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellvi, I, Alvarez, ED. COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1597. PMID:. IF:20.600(Q1/1D).
01/06/2025
DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY
Valera-Ribera, C, Alegre-Sancho, JJ, Castellvi, I, Ibanez, M, Garcia, FJN. DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3437. PMID:. IF:20.600(Q1/1D).
01/06/2025
UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA
Paños, HB, Saborit, MC, Lasanta, MAL, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernardez, J, Guillen, AG, Aguilar, JR, Cuervo, A, Roc, MV, Gomez, CG, Mínguez, S, Novell, RM, Estrada, P, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gómez-Puerta, JA, Pérez, SH, Palau, NM, Sanmarti, R, Mateo, L, Diaz-Torne, C, Corominas, H, Alarcon, GS. UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3117. PMID:. IF:20.600(Q1/1D).
01/06/2025
PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY
Avilés, A, Plaza, Z, Sánchez-Alonso, F, Castañeda, S, Fernández-Gutiérrez, B, Diaz-Torne, C, Pilar, FU, González, OM, Gallego, JMS, Giner, E, Cid, AR, Gómez, AP, Nievas, GS, García, J, Juanatey, CG, Llorca, J, González-Gay, MA, Andrés, M. PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.A1239. PMID:. IF:20.600(Q1/1D).